Prognoix
Singapore, Singapore
Prognoix is a digital health venture dedicated to creating evidence-based digital medicines tailored for stigmatized illnesses. Their primary focus lies in men's health and sexual health, notably offering Melonga, a mobile application for premature ejaculation currently available in Europe. By delivering care within the comfort and privacy of the home, they aim to overcome significant barriers such as physician shortages and patient reluctance to seek traditional help. Additionally, the company is in stealth mode developing further digital therapeutics targeting metabolic syndromes and various women's health issues to expand their clinical impact.
Company Info
- Founded
- 2018
- Website
- prognoix.com/
Categories
Disease Areas
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of Prognoix?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.